Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 30, 2024 06:10 ET
Li Auto Inc. Announces Completion of the Put Right Offer for Its 0.25% Convertible Senior Notes due 2028
Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it has completed its previously announced put right offer relating to its 0.25% Convertible Senior Notes due...
Apr 30, 2024 06:05 ET
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, announced today that the first patient in its Phase 2 clinical trial evaluating INB-400 in patients with newly diagnosed...
Apr 30, 2024 06:05 ET
MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases
MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it will proceed with a...
Apr 30, 2024 06:01 ET
Iovance Biotherapeutics to Present at Upcoming Conferences
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership...
Apr 30, 2024 06:01 ET
Oaktree Specialty Lending Corporation Announces Permanent Base Management Fee Reduction
Oaktree Specialty Lending Corporation (NASDAQ:OCSL) (“OCSL” or the “Company”) today announced a permanent reduction in its base management fee. Effective July 1, 2024, the base management fee will be reduced to an annual rate of 1.00% from 1.50% on...
Apr 30, 2024 06:00 ET
Crawford United Corporation Announces First Quarter 2024 Results
Crawford United Corporation (OTC: CRAWA), a growth-oriented holding company serving diverse markets, today reported results for the quarter ended March 31, 2024. For the quarter ended March 31, 2024, sales were $38.4 million compared with $39.5...
Apr 30, 2024 06:00 ET
H World Group Limited Announces Completion of the Put Right Offer for Its 3.00% Convertible Senior Notes due 2026
H World Group Limited (Nasdaq: HTHT and HKEx: 1179, the “Company” or “H World”), a key player in the global hotel industry, today announced that it has completed its previously announced put right offer relating to its 3.00% Convertible Senior...
Apr 30, 2024 06:00 ET
Avricore Health Corporate Update and Audited Results for 2023
AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147 while gross profit increased by...
Apr 30, 2024 06:00 ET
CNH kicks off A Sustainable Year series with a focus on AI
CNH kicks off A Sustainable Year series with a focus on AI Basildon, April 30, 2024 Today, CNH announces the first in a series of stories to be featured in its latest A Sustainable Year magazine. The annual publication promotes the...
Apr 30, 2024 06:00 ET
Comstock Announces First Quarter 2024 Results and Corporate Updates
Comstock Inc. (NYSE: LODE) (“Comstock,” “our,” and the “Company”), today announced its first quarter 2024 results, business updates and an updated 2024 business outlook. “We are pushing the boundaries of technology and sustainability, especially...
Apr 30, 2024 06:00 ET
Gentherm Reports 2024 First Quarter Results
Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced its financial results...
Apr 30, 2024 06:00 ET
Lancaster Resources Receives Drill Permit Approval for Alkali Flat Lithium Brine Project
Lancaster Resources Inc. (CSE:LCR) (OTCQB:LANRF) (FRA:6UF0) (“Lancaster”) announces that the New Mexico Mining and Minerals Division (“MMD”) has provided Lancaster with a “Technically Complete Letter” regarding a permit for the Alkali Flat Lithium...
Apr 30, 2024 06:00 ET
Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter 2024 Financial Results and Declares Quarterly Distribution of $0.55 Per Share
Oaktree Specialty Lending Corporation (NASDAQ: OCSL) (“Oaktree Specialty Lending” or the “Company”), a specialty finance company, today announced its financial results for the fiscal quarter ended March 31, 2024. Financial Highlights for the...
Apr 30, 2024 06:00 ET
Swvl Records $3.1m Net Profit, 13% Net Margin, and an Eightfold Growth in Gross Profit
Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a technology provider for enterprise and government mobility solutions with a global footprint, announces a significant achievement in its financial performance for the fiscal year 2023....
Apr 30, 2024 06:00 ET
Xage Announces AI-Powered Analytics and Insight Capabilities to Enhance Zero Trust Access and Protection
Xage Security, a global leader in zero trust access and protection, today announced new AI-powered analytics and insight capabilities. These capabilities use AI to derive actionable insights from the unique user-activity data and visibility...
Apr 30, 2024 06:00 ET
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will...
Apr 30, 2024 05:45 ET
Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access
Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that...
Apr 30, 2024 05:00 ET
CDR-Life Announces Fourth Milestone Achievement with Boehringer Ingelheim in Phase 1 Geographic Atrophy Trial
CDR-Life Inc. today announced the advancement of the Phase 1 study with BI 771716, its therapeutic candidate in partnership with Boehringer Ingelheim (BI) for the treatment of geographic atrophy (GA). This marks the achievement of the fourth...
Apr 30, 2024 05:00 ET
Fortuna renews share repurchase program
Fortuna Silver Mines Inc. (TSX: FVI) (NYSE: FSM) announced today that the Toronto Stock Exchange has approved the renewal of Fortuna’s normal course issuer bid (the “NCIB”) to purchase up to five percent of its outstanding common shares. Under...
Apr 30, 2024 05:00 ET
Fraser Institute News Release: Compliance costs for Canadians filing personal income taxes in 2023 estimated at $4.2 billion
Total compliance costs for filing personal income taxes in 2023 are estimated at $130 per Canadian tax filer, or $4.2 billion altogether, finds a new study published today by the Fraser Institute, an independent, non-partisan Canadian public policy...